265 related articles for article (PubMed ID: 28931217)
1. Prevalence of Human Papillomavirus Among Females After Vaccine Introduction-National Health and Nutrition Examination Survey, United States, 2003-2014.
Oliver SE; Unger ER; Lewis R; McDaniel D; Gargano JW; Steinau M; Markowitz LE
J Infect Dis; 2017 Sep; 216(5):594-603. PubMed ID: 28931217
[TBL] [Abstract][Full Text] [Related]
2. Declines in Prevalence of Human Papillomavirus Vaccine-Type Infection Among Females after Introduction of Vaccine - United States, 2003-2018.
Rosenblum HG; Lewis RM; Gargano JW; Querec TD; Unger ER; Markowitz LE
MMWR Morb Mortal Wkly Rep; 2021 Mar; 70(12):415-420. PubMed ID: 33764964
[TBL] [Abstract][Full Text] [Related]
3. Declines in Vaccine-Type Human Papillomavirus Prevalence in Females Across Racial/Ethnic Groups: Data From a National Survey.
McClung NM; Lewis RM; Gargano JW; Querec T; Unger ER; Markowitz LE
J Adolesc Health; 2019 Dec; 65(6):715-722. PubMed ID: 31515134
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of HPV After Introduction of the Vaccination Program in the United States.
Markowitz LE; Liu G; Hariri S; Steinau M; Dunne EF; Unger ER
Pediatrics; 2016 Mar; 137(3):e20151968. PubMed ID: 26908697
[TBL] [Abstract][Full Text] [Related]
5. Human Papillomavirus Vaccine Impact and Effectiveness Through 12 Years After Vaccine Introduction in the United States, 2003 to 2018.
Rosenblum HG; Lewis RM; Gargano JW; Querec TD; Unger ER; Markowitz LE
Ann Intern Med; 2022 Jul; 175(7):918-926. PubMed ID: 35576590
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus in young women with Chlamydia trachomatis infection 7 years after the Australian human papillomavirus vaccination programme: a cross-sectional study.
Chow EP; Danielewski JA; Fehler G; Tabrizi SN; Law MG; Bradshaw CS; Garland SM; Chen MY; Fairley CK
Lancet Infect Dis; 2015 Nov; 15(11):1314-23. PubMed ID: 26201300
[TBL] [Abstract][Full Text] [Related]
7. Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010.
Markowitz LE; Hariri S; Lin C; Dunne EF; Steinau M; McQuillan G; Unger ER
J Infect Dis; 2013 Aug; 208(3):385-93. PubMed ID: 23785124
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of Genital Human Papillomavirus in Males, United States, 2013-2014.
Gargano JW; Unger ER; Liu G; Steinau M; Meites E; Dunne E; Markowitz LE
J Infect Dis; 2017 Apr; 215(7):1070-1079. PubMed ID: 28170037
[TBL] [Abstract][Full Text] [Related]
9. Genital Human Papillomavirus Prevalence Over the Lifespan Among Females and Males in a National Cross-Sectional Survey, United States, 2013-2016.
Lewis RM; Gargano JW; Unger ER; Querec TD; Markowitz LE
Sex Transm Dis; 2021 Nov; 48(11):855-863. PubMed ID: 34009919
[TBL] [Abstract][Full Text] [Related]
10. Quadrivalent vaccine-targeted human papillomavirus genotypes in heterosexual men after the Australian female human papillomavirus vaccination programme: a retrospective observational study.
Chow EPF; Machalek DA; Tabrizi SN; Danielewski JA; Fehler G; Bradshaw CS; Garland SM; Chen MY; Fairley CK
Lancet Infect Dis; 2017 Jan; 17(1):68-77. PubMed ID: 27282422
[TBL] [Abstract][Full Text] [Related]
11. Impact of human papillomavirus vaccination on racial/ethnic disparities in vaccine-type human papillomavirus prevalence among 14-26 year old females in the U.S.
Hirth J; McGrath CJ; Kuo YF; Rupp RE; Starkey JM; Berenson AB
Vaccine; 2018 Nov; 36(50):7682-7688. PubMed ID: 30377066
[TBL] [Abstract][Full Text] [Related]
12. Association between human papillomavirus vaccine status and sexually transmitted infection outcomes among females aged 18-35 with a history of sexual activity in the United States: A population survey-based cross-sectional analysis.
Closson K; Karim ME; Sadarangani M; Naus M; Ogilvie GS; Donken R
Vaccine; 2020 Dec; 38(52):8396-8404. PubMed ID: 33239227
[TBL] [Abstract][Full Text] [Related]
13. Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study.
Tabrizi SN; Brotherton JM; Kaldor JM; Skinner SR; Liu B; Bateson D; McNamee K; Garefalakis M; Phillips S; Cummins E; Malloy M; Garland SM
Lancet Infect Dis; 2014 Oct; 14(10):958-66. PubMed ID: 25107680
[TBL] [Abstract][Full Text] [Related]
14. Declines in HPV vaccine type prevalence in women screened for cervical cancer in the United States: Evidence of direct and herd effects of vaccination.
Markowitz LE; Naleway AL; Lewis RM; Crane B; Querec TD; Weinmann S; Steinau M; Unger ER
Vaccine; 2019 Jun; 37(29):3918-3924. PubMed ID: 31160099
[TBL] [Abstract][Full Text] [Related]
15. Change in Human Papillomavirus Prevalence Among U.S. Women Aged 18-59 Years, 2009-2014.
Berenson AB; Hirth JM; Chang M
Obstet Gynecol; 2017 Oct; 130(4):693-701. PubMed ID: 28885413
[TBL] [Abstract][Full Text] [Related]
16. The impact of over ten years of HPV vaccination in England: Surveillance of type-specific HPV in young sexually active females.
Checchi M; Mesher D; Panwar K; Anderson A; Beddows S; Soldan K
Vaccine; 2023 Oct; 41(45):6734-6744. PubMed ID: 37821315
[TBL] [Abstract][Full Text] [Related]
17. Comparison of HPV prevalence between HPV-vaccinated and non-vaccinated young adult women (20-26 years).
Guo F; Hirth JM; Berenson AB
Hum Vaccin Immunother; 2015; 11(10):2337-44. PubMed ID: 26376014
[TBL] [Abstract][Full Text] [Related]
18. The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent?
Patel C; Brotherton JM; Pillsbury A; Jayasinghe S; Donovan B; Macartney K; Marshall H
Euro Surveill; 2018 Oct; 23(41):. PubMed ID: 30326995
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of Genital Human Papillomavirus Infection and Human Papillomavirus Vaccination Rates Among US Adult Men: National Health and Nutrition Examination Survey (NHANES) 2013-2014.
Han JJ; Beltran TH; Song JW; Klaric J; Choi YS
JAMA Oncol; 2017 Jun; 3(6):810-816. PubMed ID: 28114440
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of Human Papillomavirus Vaccination on Prevalence of Vaccine Genotypes in Young Sexually Active Women in France.
Heard I; Tondeur L; Arowas L; Demazoin M; Falguières M; Parent Du Chatelet I;
J Infect Dis; 2017 Mar; 215(5):757-763. PubMed ID: 28011911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
